Factors influencing hemorrhagic transformation in ischemic stroke patients with atrial fibrillation: a hospital based-study

Table 1 Baseline characteristics of the patients group

Variables		Characteristic of ischemic stroke with AF (234)
Age^a		64.04 (± 9.58)
Gender^b (male)		119 (50.9%)
Hypertension^b		134 (57.3%)
Diabetes mellitus^b		95 (40.6%)
Smoking^b		47 (20.1%)
Dyslipidemia^b		92 (39.3%)
Previous stroke/TIA^b		38 (16.2%)
Ischemic heart disease^b		73 (31.2%)
Antiplatelets^b		67 (28.6%)
Anticoagulants^b		75 (32.1%)
Anticoagulant duration (years)^a		0.70 (± 1.33)
SBP^a		146.11 (± 23.59)
DBP^a		85.58 (± 10.39)
FBS^a		133.27 (± 48.97)
Total leukocyte count^a		10.84 (± 6.03)
Platelets count^a		240.14 (± 66.37)
International normalized ratios^a		1.26 (± 0.37)
Total cholesterol^a		192.82 (± 49.82)
LDL-C^a		129.82 (± 41.53)
HDL-C^a		42.51 (± 13.99)
Triglycerides^a		123.46 (± 50.40)
ESR^a		29.48 (± 5.83)
CRP^a		11.76 (± 10.18)
Creatinine^a		0.75 (± 0.21)
GCS^a		13.01 (± 2.38)
NIHSS^c		14 (8–18)
Hemorrhagic transformation^b		53 (22.6%)
Infarction size^b	Small	83 (35.5%)
	Medium	73 (31.2%)
	Large	78 (33.3%)
CMB^b	0	139 (59.4%)
	< 10	60 (25.6%)
	≥ 10	35 (15%)
Superficial siderosis^b		38 (16.2%)
WML^b		97 (41.5%)
CNS atrophy^b		90 (38.5%)

TIA transient ischemic attack, HDL high-density lipoprotein-cholesterol, LDL low-density lipoprotein-cholesterol, ESR erythrocyte sedimentation rate, CRP C-reactive protein, GCS Glasgow Coma Scale, NIHSS National Institutes of Health Stroke Scale, CMB cerebral microbleed, WML white matter lesions
^aMean (± SD)
^bN (%)
^cMedian (IQR)
^*significant at alpha level of significance ≤ 0.05